Robotic high-intensity focused ultrasound for prostate cancer: what have we learned in 15 years of clinical use? (Q37856802)

24 August 2017

1 reference

title

Robotic high-intensity focused ultrasound for prostate cancer: what have we learned in 15 years of clinical use? (English)

1 reference

24 August 2017

0 references

1 reference

Christian G Chaussy

1

1 reference

24 August 2017

Stefan F Thüroff

series ordinal

2

1 reference

24 August 2017

publication date

1 June 2011

1 reference

24 August 2017

published in

Current urology reports

1 reference

24 August 2017

volume

12

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

180-187

1 reference

Balancing the harms and benefits of early detection of prostate cancer.

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0184-2

Technology insight: High-intensity focused ultrasound for urologic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0184-2

Results and side effects of high-intensity focused ultrasound in localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0184-2

Transrectal high intensity focused ultrasound for the treatment of localized prostate cancer: factors influencing the outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0184-2

High-Intensity Focused Ultrasound and Localized Prostate Cancer: Efficacy Results from the European Multicentric Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0184-2

High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0184-2

Short-term outcome after high-intensity focused ultrasound in the treatment of patients with high-risk prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0184-2

Control of prostate cancer by transrectal HIFU in 227 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0184-2

First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0184-2

High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0184-2

Multicentric oncologic outcomes of high-intensity focused ultrasound for localized prostate cancer in 803 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0184-2

Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0184-2

[Transrectal high-intensity focused ultrasound for local treatment of prostate cancer. 2009 Update].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0184-2

Careful Selection and Close Monitoring of Low-Risk Prostate Cancer Patients on Active Surveillance Minimizes the Need for Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0184-2

Active surveillance for prostate cancer: for whom?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0184-2

Focal prostate cryoablation: initial results show cancer control and potency preservation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0184-2

Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0184-2

Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0184-2

Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0184-2

The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0184-2

High-intensity focused ultrasound therapy for clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0184-2

High-intensive focused ultrasound in localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0184-2

High-intensity focused ultrasound in the management of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0184-2

Quality of life following high-intensity focused ultrasound for the treatment of localized prostate cancer: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0184-2

Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0184-2

A prospective study of salvage high-intensity focused ultrasound for locally radiorecurrent prostate cancer: early results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0184-2

Activated anti-tumor immunity in cancer patients after high intensity focused ultrasound ablation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0184-2

Expression of tumor antigens and heat-shock protein 70 in breast cancer cells after high-intensity focused ultrasound ablation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0184-2

Investigation of HIFU-induced anti-tumor immunity in a murine tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0184-2

Increased infiltration of activated tumor-infiltrating lymphocytes after high intensity focused ultrasound ablation of human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0184-2

Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0184-2

Nomogram use for the prediction of indolent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11934-011-0184-2

High-intensity focused ultrasound: complications and adverse events.

21 January 2018

1 reference

12 December 2020

Focal "nerve-sparing" cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency

1 reference

12 December 2020

Active surveillance for prostate cancer: patient selection and management.

1 reference

12 December 2020

A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer

1 reference

12 December 2020

[Results of transrectal focused ultrasound for the treatment of localized prostate cancer (120 patients with PSA < or + 10ng/ml].

1 reference

12 December 2020

"Male lumpectomy": focal therapy for prostate cancer using cryoablation

1 reference

12 December 2020

The early diagnosis and radical cure of carcinoma of the prostate. Being a study of 40 cases and presentation of a radical operation which was carried out in four cases. 1905.

1 reference

12 December 2020

10.1007/S11934-011-0184-2

Identifiers

DOI

1 reference

24 August 2017

1 reference